Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 1900 in its research report dated3, 2025.

Across the recent three months, 4 analysts have shared their insights on Marriott Vacations (NYSE: VAC ), expressing a ...

Nicolò Bernardini, Edoardo Ciccarelli, Nicola Baresi, Roberto Armellin (2023)SUCCESSIVE CONVEX PROGRAMMING FOR HIGH-ORDER GUIDANCE AND NAVIGATION OF SATELLITES, In: Proceedings of the 2023 AAS/AIAA ...

Vertiv, Ameren, Universal Health Services, Aptiv and FirstCash stand out with strong 2025 sales growth despite market uncertainty.

Insights from analysts' 12-month price targets are revealed, presenting an average target of $83.83, a high estimate of ...

Grew Total Revenue 10% Year-over-Year to $137.0 Million - - Assets Under Management (“AuM”) Increased 11% Year-over-Year to $30.0 Billion - - ...

Adoptees’ higher ADHD rates reflect genetic, prenatal, and social factors, highlighting the need for trauma-informed, adoption-competent care and systemic equity.

Acute kidney injury (AKI) is among the most common organ failures observed in the hospital and can irrevocably alter the trajectory of a patient's short-term and long-term health.1–4 The lack of ...

Q3 2025 Earnings Call Transcript November 10, 2025 DocGo Inc. misses on earnings expectations. Reported EPS is $-0.11 EPS, ...

Detailed price information for Solaris Resources Inc (SLS-T) from The Globe and Mail including charting and trades.

Company delivers profitable growth with record high quarterly Revenue and Gross Merchandise Value, strengthening its ...

Consolidates messaging around Einstein Rx AI, Wellgistics Hub (formerly DelivMeds) and HubRx AI integration with pharmacies (in-house pharmacy and 6,500+ independent pharmacy network), physicians and ...